(19)
(11) EP 1 551 418 A1

(12)

(43) Date of publication:
13.07.2005 Bulletin 2005/28

(21) Application number: 03752401.4

(22) Date of filing: 18.09.2003
(51) International Patent Classification (IPC)7A61K 31/685, A61K 31/66, C07F 9/40, C07F 9/38
(86) International application number:
PCT/US2003/029080
(87) International publication number:
WO 2004/026315 (01.04.2004 Gazette 2004/14)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
Designated Extension States:
AL LT LV MK

(30) Priority: 19.09.2002 US 412091 P

(71) Applicant: Ilex Oncology Research Sàrl
1290 Versoix (CH)

(72) Inventors:
  • NGUYEN, Lân Mong
    CH-1260 Nyon (CH)
  • DIEP, Vinh Van
    74100 Vétraz-Monthoux (FR)
  • PHAN, Hieu, Trung
    CH-1295 Tannay (CH)
  • NIESOR, Eric, Joseph
    CH-1260 Nyon (CH)
  • MASSON, Daniele
    CH-1009 Pully (CH)
  • GUYON-GELLIN, Yves
    F-74100 Annemasse (FR)
  • BUATTINI, Emanuele
    CH-1207 Genève (CH)
  • SEVERI, Carlo
    CH-1219 Le Lignon (CH)
  • AZOULAY, Raymond
    CH-1208 Genève (CH)
  • BENTZEN, Craig, Leigh
    CH-1279 Bogis-Bossey (CH)

(74) Representative: Glawe. Delfs. Moll 
PatentanwältePostfach 26 01 62
80058 München
80058 München (DE)

   


(54) SUBSTITUTED KETOPHOSPHONATE COMPOUNDS HAVING BONE ANABOLIC ACTIVITY